Alprostadil detailed information

Revision as of 22:01, 8 August 2012 by WikiBot (talk | contribs) (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Jump to navigation Jump to search
Alprostadil detailed information
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC20H34O5
Molar mass354.481 g/mol

WikiDoc Resources for Alprostadil detailed information

Articles

Most recent articles on Alprostadil detailed information

Most cited articles on Alprostadil detailed information

Review articles on Alprostadil detailed information

Articles on Alprostadil detailed information in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Alprostadil detailed information

Images of Alprostadil detailed information

Photos of Alprostadil detailed information

Podcasts & MP3s on Alprostadil detailed information

Videos on Alprostadil detailed information

Evidence Based Medicine

Cochrane Collaboration on Alprostadil detailed information

Bandolier on Alprostadil detailed information

TRIP on Alprostadil detailed information

Clinical Trials

Ongoing Trials on Alprostadil detailed information at Clinical Trials.gov

Trial results on Alprostadil detailed information

Clinical Trials on Alprostadil detailed information at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Alprostadil detailed information

NICE Guidance on Alprostadil detailed information

NHS PRODIGY Guidance

FDA on Alprostadil detailed information

CDC on Alprostadil detailed information

Books

Books on Alprostadil detailed information

News

Alprostadil detailed information in the news

Be alerted to news on Alprostadil detailed information

News trends on Alprostadil detailed information

Commentary

Blogs on Alprostadil detailed information

Definitions

Definitions of Alprostadil detailed information

Patient Resources / Community

Patient resources on Alprostadil detailed information

Discussion groups on Alprostadil detailed information

Patient Handouts on Alprostadil detailed information

Directions to Hospitals Treating Alprostadil detailed information

Risk calculators and risk factors for Alprostadil detailed information

Healthcare Provider Resources

Symptoms of Alprostadil detailed information

Causes & Risk Factors for Alprostadil detailed information

Diagnostic studies for Alprostadil detailed information

Treatment of Alprostadil detailed information

Continuing Medical Education (CME)

CME Programs on Alprostadil detailed information

International

Alprostadil detailed information en Espanol

Alprostadil detailed information en Francais

Business

Alprostadil detailed information in the Marketplace

Patents on Alprostadil detailed information

Experimental / Informatics

List of terms related to Alprostadil detailed information

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Alprostadil is the pharmaceutical name for prostaglandin E1. It is used as a drug in the treatment of erectile dysfunction and has vasodilatory properties.[1]

Sexual dysfunction

Aprostidil is sold in the United States under the brand name Muse.[2] It is also sold as Caverject and Edex.

Muse delivers alprostadil as a penile suppository, inserted into the urethra, at least ten minutes before the erection will be needed. Caverject and Edex are similarly fast-acting, but are actually injected directly into the corpus cavernosum of the penis.

This drug is reputed to work for erectile dysfunction for 30 to 60 minutes.

This drug, following on the coattails of Viagra, has failed to achieve comparable above-ground market share in the United States, perhaps in part because of the invasive means of delivery.

NexMed is developing transdermal forumulations—Alprox-TD(R) for men with erectile dysfunction and Femprox(R) for female sexual arousal disorder. Alprox-TD(R) has been selling in China and in Hong Kong since October 2001 and April 2002, respectively. Two Phase III studies have been completed for this product, and the Company is seeking regulatory approval in the U.S., Canada and Europe. [3]

Other uses

Aprostadil is also used in maintaining a patent ductus arteriosus in the fetus. This is primarily useful when there is threat of premature closure of the ductus arteriosus.[1]

References

  1. 1.0 1.1 Template:Dorlands
  2. Muse.
  3. Fain Hughes (2007-10-29). "NEXM: Dutton Sees Strong Speculative Buy and 12-Month Price Double". Retrieved 2007-11-01.


Template:Prostaglandins


Template:WikiDoc Sources